ข่าวฟอเร็กซ์

European Stocks Fail To Hold Early Gains, Close Broadly Lower

European Stocks Fail To Hold Early Gains, Close Broadly Lower

European stocks failed to hold early gains and closed lower on Monday as investors largely stayed cautious ahead of key U.S. inflation data, and other economic reports from the U.S. and Europe.
RTTNews | 188 วันที่ผ่านมา
Rate Cut Outlook Drove Dollar's Moves Last Week

Rate Cut Outlook Drove Dollar's Moves Last Week

Monetary policy expectations from the Federal Reserve predominantly drove the Dollar's movements during the week spanning May 6 to May 10.
RTTNews | 188 วันที่ผ่านมา
Axalta Coating To Acquire CoverFlexx Group For $285 Mln Plus Potential $10 Mln Earnout

Axalta Coating To Acquire CoverFlexx Group For $285 Mln Plus Potential $10 Mln Earnout

Coatings company Axalta Coating Systems (AXTA) announced Monday that it has entered into a definitive agreement to acquire The CoverFlexx Group from Transtar Holding Co. for initial cash consideration of $285 million, plus an additional $10 million earnout based on the business' 2024 performance.
RTTNews | 189 วันที่ผ่านมา
Bay Street Likely To Open On Mixed Note

Bay Street Likely To Open On Mixed Note

Canadian shares are likely to open on a mixed note Monday morning, with investors tracking earnings updates and commodity markets for direction. The mood is likely to remain cautious ahead of U.S. inflation data and Fed Chair Jerome Powell's speech, due later in the week.
RTTNews | 189 วันที่ผ่านมา
more news
Merus Says FDA Grants Breakthrough Therapy Designation For Petosemtamab To Treat Head & Neck Cancer

Merus Says FDA Grants Breakthrough Therapy Designation For Petosemtamab To Treat Head & Neck Cancer

Oncology company Merus N.V. (MRUS) announced Monday that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation (BTD) for petosemtamab for the treatment of patients with recurrent or metastatic head and neck squamous cell carcinoma (HNSCC) whose disease has progressed following treatment with platinum based chemotherapy and an anti-programmed cell death receptor-1 (PD-1) or anti-programmed death ligand 1 (PD-L1) antibody.
RTTNews | 189 วันที่ผ่านมา
V2X Appoints Jeremy Wensinger To Succeed Chuck Prow As President And CEO

V2X Appoints Jeremy Wensinger To Succeed Chuck Prow As President And CEO

V2X, Inc. (VVX), a leading provider of global mission solutions, announced Monday that Jeremy Wensinger has been appointed President, Chief Executive Officer and a member of the company's Board of Directors, effective as of June 17, 2024. Wensinger is succeeding Chuck Prow.
RTTNews | 189 วันที่ผ่านมา
Permira To Take Squarespace Private In $6.9 Bln All-cash Deal

Permira To Take Squarespace Private In $6.9 Bln All-cash Deal

Design-driven platform Squarespace, Inc. (SQSP) announced Monday that it has entered into a definitive agreement to go private by private equity firm Permira in an all-cash transaction valued at approximately $6.9 billion.
RTTNews | 189 วันที่ผ่านมา
Sensex, Nifty End Modestly Higher After Volatility

Sensex, Nifty End Modestly Higher After Volatility

Indian shares ended modestly higher on Monday, after having fallen deep into the red earlier in the session due to uncertainty surrounding the general election results.
RTTNews | 189 วันที่ผ่านมา
Amazon, Microsoft, Pfizer To Invest Billions In French Projects

Amazon, Microsoft, Pfizer To Invest Billions In French Projects

Major companies, including Amazon.com Inc., Microsoft Corp., Morgan Stanley, Pfizer and others, have announced around 15 billion euros or $16.2 billion worth foreign investments in France as part of the country's annual 'Choose France' business summit, reports said. French President Emmanuel Macron kicks off the summit of 180 CEOs and executives on Monday, aiming to showcase foreign investment.
RTTNews | 189 วันที่ผ่านมา

Stay up to date!

Add ข่าว to your browser

Extension Picture